Dr. Sean S. Armin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12626 Riverside Dr., 103, Valley Village, CA 91607 Phone: 818-766-6895 Fax: 951-683-6626 |
News Archive
Researchers at the University of Alabama at Birmingham Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.
An innovative treatment technology could give cancer patients new hope for survival. In an international study based at Lawson Health Research Institute and London Health Sciences Centre's London Regional Cancer Program (LRCP), scientists are testing a therapy with the potential to eradicate cancers previously thought to be incurable.
A new study shows that the CA125 blood test, which measures the level of protein produced by ovarian cancer cells in the blood, may be superior to standard imaging techniques like CT scans in predicting survival in patients with recurrent ovarian cancer.
Salt of the Earth Ltd. introduces a novel, low-sodium sea salt ingredient to address food manufacturers' challenges to reduce sodium in bakery products, such as bread, breakfast cereals and snacks.
Tooth decay affects children in the United States more than any other chronic infectious disease, according to the Centers for Disease Control and Prevention (CDC). The CDC states that tooth decay, if left untreated, can cause pain and infections that hinder eating, speaking, playing and learning.
› Verified 3 days ago